Antalis C - Search Results

1

Elevated and secreted phospholipase A₂ activities as new potential therapeutic targets in human epithelial ovarian cancer.

Cai Q, Zhao Z, Antalis C, Yan L, Del Priore G, Hamed AH, Stehman FB, Schilder JM, Xu Y. Cai Q, et al. Among authors: antalis c. FASEB J. 2012 Aug;26(8):3306-20. doi: 10.1096/fj.12-207597. Epub 2012 Jul 5. FASEB J. 2012. PMID: 22767227 Free PMC article.

2

Combination therapy of an inhibitor of group VIA phospholipase A2 with paclitaxel is highly effective in blocking ovarian cancer development.

Li H, Zhao Z, Antalis C, Zhao Z, Emerson R, Wei G, Zhang S, Zhang ZY, Xu Y. Li H, et al. Among authors: antalis c. Am J Pathol. 2011 Jul;179(1):452-61. doi: 10.1016/j.ajpath.2011.03.027. Epub 2011 May 17. Am J Pathol. 2011. PMID: 21703423 Free PMC article.

3

Migration of MDA-MB-231 breast cancer cells depends on the availability of exogenous lipids and cholesterol esterification.

Antalis CJ, Uchida A, Buhman KK, Siddiqui RA. Antalis CJ, et al. Clin Exp Metastasis. 2011 Dec;28(8):733-41. doi: 10.1007/s10585-011-9405-9. Epub 2011 Jul 9. Clin Exp Metastasis. 2011. PMID: 21744083

4

High ACAT1 expression in estrogen receptor negative basal-like breast cancer cells is associated with LDL-induced proliferation.

Antalis CJ, Arnold T, Rasool T, Lee B, Buhman KK, Siddiqui RA. Antalis CJ, et al. Breast Cancer Res Treat. 2010 Aug;122(3):661-70. doi: 10.1007/s10549-009-0594-8. Epub 2009 Oct 23. Breast Cancer Res Treat. 2010. PMID: 19851860

5

Docosahexaenoic acid is a substrate for ACAT1 and inhibits cholesteryl ester formation from oleic acid in MCF-10A cells.

Antalis CJ, Arnold T, Lee B, Buhman KK, Siddiqui RA. Antalis CJ, et al. Prostaglandins Leukot Essent Fatty Acids. 2009 Feb-Mar;80(2-3):165-71. doi: 10.1016/j.plefa.2009.01.001. Epub 2009 Feb 13. Prostaglandins Leukot Essent Fatty Acids. 2009. PMID: 19217763

6

Trans-fatty acids induce pro-inflammatory responses and endothelial cell dysfunction.

Harvey KA, Arnold T, Rasool T, Antalis C, Miller SJ, Siddiqui RA. Harvey KA, et al. Among authors: antalis c. Br J Nutr. 2008 Apr;99(4):723-31. doi: 10.1017/S0007114507842772. Epub 2007 Oct 10. Br J Nutr. 2008. PMID: 17925051

7

Omega-3 fatty acid status in attention-deficit/hyperactivity disorder.

Antalis CJ, Stevens LJ, Campbell M, Pazdro R, Ericson K, Burgess JR. Antalis CJ, et al. Prostaglandins Leukot Essent Fatty Acids. 2006 Oct-Nov;75(4-5):299-308. doi: 10.1016/j.plefa.2006.07.004. Epub 2006 Sep 8. Prostaglandins Leukot Essent Fatty Acids. 2006. PMID: 16962757

8

Genetic variation in bitter taste and plasma markers of anti-oxidant status in college women.

Tepper BJ, Williams TZ, Burgess JR, Antalis CJ, Mattes RD. Tepper BJ, et al. Int J Food Sci Nutr. 2009;60 Suppl 2:35-45. doi: 10.1080/09637480802304499. Epub 2008 Nov 12. Int J Food Sci Nutr. 2009. PMID: 19012068

9

Prevention of Growth Failure in Turner Syndrome: Long-Term Results of Early Growth Hormone Treatment in the "Toddler Turner" Cohort.

Quigley CA, Fechner PY, Geffner ME, Eugster EA, Ross JL, Habiby RL, Ugrasbul F, Rubin K, Travers S, Antalis CJ, Patel HN, Davenport ML. Quigley CA, et al. Among authors: antalis cj. Horm Res Paediatr. 2021;94(1-2):18-35. doi: 10.1159/000513788. Epub 2021 Jun 10. Horm Res Paediatr. 2021. PMID: 34111870 Clinical Trial.

10

The Evolution of Insulin and How it Informs Therapy and Treatment Choices.

Hirsch IB, Juneja R, Beals JM, Antalis CJ, Wright EE. Hirsch IB, et al. Among authors: antalis cj. Endocr Rev. 2020 Oct 1;41(5):733-55. doi: 10.1210/endrev/bnaa015. Endocr Rev. 2020. PMID: 32396624 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

16 results

Search Page

Filters